Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...

ver descrição completa

Detalhes bibliográficos
Main Authors: Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara
Formato: Artigo
Idioma:English
Publicado em: Wiley 2018-07-01
Colecção:Reproductive Medicine and Biology
Assuntos:
assisted reproductive technology
atypical endometrial hyperplasia
conservative treatment
endometrial carcinoma
medroxyprogesterone acetate
Acesso em linha:https://doi.org/10.1002/rmb2.12209

Registos relacionados

Registos relacionados